These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 271755)

  • 21. A comparison of the behavioral effects of proteo-and deutero-N, N-dimethyltryptamine.
    Beaton JM; Barker SA; Liu WF
    Pharmacol Biochem Behav; 1982 May; 16(5):811-4. PubMed ID: 6806829
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1980 May; 69(1):69-80. PubMed ID: 6769527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats.
    Walters JK; Sheard MH; Davis M
    Pharmacol Biochem Behav; 1978 Jul; 9(1):87-90. PubMed ID: 279938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.
    Fuxe K; Holmstedt B; Jonsson G
    Eur J Pharmacol; 1972 Jul; 19(1):25-34. PubMed ID: 4403108
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.
    Vaccari A; Del Zompo M; Melis F; Gessa GL; Rossetti ZL
    Br J Pharmacol; 1991 Nov; 104(3):573-4. PubMed ID: 1797320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex.
    Davis M; Sheard MH
    Pharmacol Biochem Behav; 1974; 2(6):827-9. PubMed ID: 4533618
    [No Abstract]   [Full Text] [Related]  

  • 28. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
    Glennon RA; Rosecrans JA; Young R; Gaines J
    Life Sci; 1979 Mar; 24(11):993-7. PubMed ID: 286864
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    Gramsch C; Bläsig J; Herz A
    Eur J Pharmacol; 1977 Aug; 44(3):231-40. PubMed ID: 560969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of central catecholamine metabolism following acute administration of ethanol.
    Liljequist S; Carlsson A
    J Pharm Pharmacol; 1978 Nov; 30(11):728-30. PubMed ID: 31442
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain norepinephrine metabolism and shock-induced fighting behavior in rats: differential effects of shock and fighting on the neurochemical response to a common footshock stimulus.
    Stolk JM; Conner RL; Levine S; Barchas JD
    J Pharmacol Exp Ther; 1974 Aug; 190(2):193-209. PubMed ID: 4475690
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical aspects of dopamine agonists.
    Kehr W; Carlsson A; Lindqvist M
    Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of scopolamine on the cerebral accumulation of 14 C-catecholamines from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Pharmacology; 1972; 8(4):291-9. PubMed ID: 4657977
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoamines in brain and adrenal glands of cats after electrically induced defense reaction.
    Gunne LM; Lewander T
    Acta Physiol Scand; 1966; 67(3):405-10. PubMed ID: 5967604
    [No Abstract]   [Full Text] [Related]  

  • 35. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism.
    Hoffmann PC; Toon R; Kleinman J; Heller A
    J Neurochem; 1973 Jan; 20(1):69-80. PubMed ID: 4687208
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance to behavioral effects of N, N-dimethyltryptamine in mice.
    Cooper SG; Schiff SR; Bridger WH
    Biol Psychiatry; 1981 Sep; 16(9):861-7. PubMed ID: 6794656
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of N,N-dimethyltryptamine with central neuroaminergic receptor blocking agents.
    Quock RM; Lum MH; Small SF
    Proc West Pharmacol Soc; 1979; 22():217-8. PubMed ID: 292978
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of N,N-dimethyltryptamine on behavioural habituation in the rat.
    File SE
    Pharmacol Biochem Behav; 1977 Feb; 6(2):163-8. PubMed ID: 266219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of hypothalamic norepinephrine by food deprivation and interaction with D-amphetamine.
    Glick SD; Waters DH; Milloy S
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):775-8. PubMed ID: 4750114
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.
    Gillin JC; Tinklenberg J; Stoff DM; Stillman R; Shortlidge JS; Wyatt RJ
    Biol Psychiatry; 1976 Jun; 11(3):355-8. PubMed ID: 820383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.